GH1 and fatty liver disease: However, only a few clinical studies have explored the potential link between SARS-CoV-2 infections and the growth hormone (GH)/insulin-like growth factor–1 (IGF-1) axis [9,10] and between liver steatosis and COVID-19 severity [11,12,13].